Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
43.78%
Operating Margin
43.38%
Net Margin
41.90%
Efficiency Metrics
Revenue per Expense Ratio
1.77
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
90.97%
Income Tax Rate
3.11%
EPS
2.8000000000
Balance Sheet Analysis
Current Ratio
0.70
Cash Ratio
0.43
Working Capital
$-132.91M
Debt to Equity
87.41
Debt to Assets
48.39%
Equity Ratio
0.55%
Cash Flow Analysis
Operating Cash Flow Ratio
49.90%
Free Cash Flow Ratio
29.54%
CapEx to Revenue
20.36%
Dividends Paid
$74.94M
Stock Buybacks
$3.97M
Total Shareholder Returns
$78.91M
Cash Position Change
-30.66%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 159.44%
Detailed Growth Metrics
Core Performance
Revenue
16.38%
Net Income
35.90%
EPS
25.56%
Operating Income
77.77%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-11.34%
Operating Cash Flow
31.03%
Free Cash Flow
27.22%
Balance Sheet Health
Assets
-1.86%
Debt
-12.21%
Book Value per Share
0.48%
Inventory
-112.17%
Shareholder Returns
Dividends per Share
159.44%
Shares Outstanding
12.81%
Long Term Trends
3Y Revenue/Share
0.89%
5Y Revenue/Share
13.43%
3Y Dividend/Share
-41.10%
5Y Dividend/Share
-15.08%